Evogene Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evogene Stock Summary

Evogene competes with Arcus Biosciences, Fate Therapeutics, Pluri, Lexaria Bioscience, and ZyVersa Therapeutics. Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Evogene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Evogene Key Financial Ratios

Evogene Key Balance Sheet Accounts

Evogene Key Income Statement Accounts

Evogene Key Cash Accounts

Evogene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Evogene's current stock value. Our valuation model uses many indicators to compare Evogene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evogene competition to find correlations between indicators driving Evogene's intrinsic value. More Info.Evogene is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Evogene's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evogene's earnings, one of the primary drivers of an investment's value.

Evogene Systematic Risk

Today, most investors in Evogene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evogene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Evogene growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Evogene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evogene. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evogene based on widely used predictive technical indicators. In general, we focus on analyzing Evogene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evogene's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.